Skip to main content
Psoriatic Arthritis ICYMI
FULL MENU
FULL MENU
Presented by
MDedge
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
MDedge Crosswords
Psoriatic Arthritis Pathophysiology & Etiology
Publish date:
October 3, 2019
Recommended Reading
FDA finds increased blood clot, death risk associated with Xeljanz
Psoriatic Arthritis ICYMI
Psoriasis patients on biologics show improved heart health
Psoriatic Arthritis ICYMI
PROMIS tools provide useful data for managing rheumatology patients
Psoriatic Arthritis ICYMI
EULAR updates vaccination recommendations for autoimmune inflammatory rheumatic disease patients
Psoriatic Arthritis ICYMI
Cannabidiol may interact with rheumatologic drugs
Psoriatic Arthritis ICYMI
Long-term advantages may not endure after early tight control in psoriatic arthritis
Psoriatic Arthritis ICYMI
Obesity, moderate drinking linked to psoriatic arthritis
Psoriatic Arthritis ICYMI
PsA Fast Facts: Comorbidities
Psoriatic Arthritis ICYMI
Psoriatic Arthritis Overview
Psoriatic Arthritis ICYMI
Prior authorizations for infusibles cause delays, toxicities
Psoriatic Arthritis ICYMI
Psoriatic Arthritis
FULL MENU
FULL MENU
Presented by
FULL MENU
FULL MENU
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
More
MDedge
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
More
MDedge